Zentek Ltd. Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement

Rhea-AI Summary

Zentek (NASDAQ: ZTEK) was granted a 180‑day extension to regain compliance with Nasdaq's $1.00 minimum bid price rule, extending the cure period to August 24, 2026. The company must maintain a closing bid of at least $1.00 for ten consecutive business days on or before that date. There is no immediate effect on listing or trading; shares will continue to trade under ZTEK. Management says it will monitor the bid price and consider available options to regain compliance.

Positive

• Nasdaq granted a 180‑day extension to August 24, 2026
• No immediate trading suspension; shares continue trading under ZTEK

Negative

• Must maintain a closing bid ≥ $1.00 for 10 consecutive business days
• Initial 180‑day cure period expired on February 23, 2026

GUELPH, ON / ACCESS Newswire / February 25, 2026 / Zentek Ltd. ("Zentek"or the "Company") (TSXV:ZEN)(NASDAQ:ZTEK) announces that, further to its press release dated August 27, 2025, it has been granted a 180 calendar day extension from The Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Rule") for continued listing on Nasdaq (the "Minimum Bid Price Requirement"), following the expiration of the initial 180 calendar day period to regain compliance on February 23, 2026. The Company now has until August 24, 2026, to meet the Minimum Bid Price Requirement set forth in Nasdaq Listing Rule 5550(a)(2).

There is no immediate effect on the listing or trading of the Company's shares, which will continue to trade on the Nasdaq under the symbol "ZTEK." To regain compliance with the Rule, the Company must maintain a closing bid price of at least $1.00 per share for a minimum of ten (10) consecutive business days on or prior to August 24, 2026. Zentek's management intends to actively monitor the bid price for its Shares and will consider all available options to regain compliance with the Nasdaq minimum bid price requirement.

About Zentek Ltd.

Zentek Ltd. is a Canadian company advancing a portfolio of graphene‑enabled advanced material technologies across healthcare, clean air and next‑generation industrial applications. Zentek develops and scales materials‑innovation solutions that aim to make partner products better, safer and more energy‑efficient, while unlocking new high‑value markets for ultra‑high‑purity graphite in nuclear, battery and semiconductor applications.

For further information:

Mohammed (Moe) Jiwan
Chief Executive Officer
Phone: 647-287-9582
Email: mjiwan2@zentek.com

To find out more about Zentek, please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at http://www.sedarplus.ca/.

Forward-Looking Statements

This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek refuses any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Zentek Ltd.

View the original press release on ACCESS Newswire

FAQ

What extension did Zentek (ZTEK) receive from Nasdaq on February 25, 2026?

Zentek received a 180‑day extension to regain compliance, moving the deadline to August 24, 2026. According to the company, this extends the cure period after the initial period expired on February 23, 2026 and preserves the company's Nasdaq listing while it seeks compliance.

What is the Nasdaq minimum bid price requirement Zentek (ZTEK) must meet by August 24, 2026?

Zentek must maintain a closing bid price of at least $1.00 for ten consecutive business days. According to the company, meeting that condition on or before August 24, 2026 is required to regain compliance with Nasdaq Listing Rule 5550(a)(2).

Will Zentek (ZTEK) shares be suspended from Nasdaq while it seeks compliance?

No, there is no immediate effect on the listing or trading of Zentek shares. According to the company, shares will continue trading on Nasdaq under the symbol ZTEK while the company monitors the bid price and evaluates options to regain compliance.

What options can Zentek (ZTEK) consider to regain Nasdaq compliance before August 24, 2026?

The company said it will consider all available options to regain compliance, including actions to increase the bid price. According to the company, management intends to actively monitor the share price and may pursue standard corrective measures permitted by Nasdaq rules.

When did Zentek's initial Nasdaq compliance period expire for ZTEK?

The initial 180‑day period expired on February 23, 2026. According to the company, Nasdaq then granted an additional 180 calendar days, extending the compliance deadline to August 24, 2026 to allow time to meet the $1.00 bid requirement.

How long must ZTEK maintain a $1.00 closing bid to satisfy Nasdaq rules?

Zentek must maintain a closing bid of at least $1.00 for ten consecutive business days. According to the company, achieving that ten‑day streak on or before August 24, 2026 will restore compliance with Nasdaq Listing Rule 5550(a)(2).